Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK.

Related documents

• Exhibiting failure toward building a growth mindset: a qualitative study of psychiatric trainees' experiences of a monthly reflective session.#1159077
• Prevalence and determinants of multimorbidity in older Chinese adults: a nationwide cross-sectional study using CLASS data.#1159078
• Diagnostic coding combination patterns, CHS-DRG severity stratification, and hospitalization expenditure in pneumonia with coexisting hypertension or diabetes mellitus: a single-center cautionary case study of definitional circularity.#1159079
• A successful model for KSA-based payor-provider collaborative in maternity care.#1159080
• The health outcomes of shelter and settlements interventions in humanitarian crises: a systematic review.#1159081